益丰药房 (603939)

Yifeng Pharmacy Chain Co., Ltd.

ASH

K-Line Chart

No K-line data available

Company NameYifeng Pharmacy Chain Co., Ltd.
Listing Date2015-02-17
Issue Price19.47RMB
Registered Capital121239.189710k RMB
Legal RepresentativeGao Yi
Registered AddressNo. 2638 Renmin Road, Fuqiang Community, Baimahu Subdistrict, Wuling District, Changde City, Hunan Province
IndustryPharmaceutical Commerce
Main BusinessChain retail of pharmaceuticals, health products, medical devices, and health-related daily convenience goods.
Company ProfileYifeng Pharmacy, a listed pharmacy chain on the Shanghai Stock Exchange Main Board, is a large-scale pharmaceutical retail chain enterprise in China. As of the end of 2015, the company had established 1,065 directly-operated pharmacy chain stores in six provinces/municipalities: Hunan, Hubei, Shanghai, Jiangsu, Zhejiang, and Jiangxi, ranking among the top five in comprehensive strength and competitiveness of national chain pharmacies. The company will remain focused on the pharmaceutical retail industry in the long term. Over the next three years, it will continue to concentrate on Central-South and East China, steadily expand into adjacent markets, and continuously enhance its core competitiveness through brand image, professional services, product innovation, and innovation in pharmaceutical e-commerce business models, aiming to build a leading chain pharmacy brand trusted by customers and respected by society.

Stock Details

1. Key Indicators

  • Total Shares(W): 121241.74
  • Circulating A-Shares(W): 121239.19
  • Earnings Per Share(RMB): 1.0100
  • Net Assets Per Share(RMB): 9.0365
  • Operating Revenue(W RMB): 1728589.99
  • Total Profit(W RMB): 176995.57
  • **Net Profit Attributable to Parent(W RMB) **: 122455.58
  • Net Profit Growth Rate(%): 10.27
  • Weighted Return on Equity(%): 11.0500
  • Operating Cash Flow Per Share(RMB): 1.8700
  • Undistributed Profit Per Share(RMB): 4.7590
  • Capital Reserve Per Share(RMB): 3.0116

2. Main Business

The main business covers:

  • Chain retail business of pharmaceuticals, health products, medical devices, and health-related daily convenience goods

3. Company Basic Information

  • Company Name: Yifeng Pharmacy Chain Co., Ltd.
  • Listing Date: 2015-02-17
  • Industry: Pharmaceuticals & Healthcare - Pharmaceutical Commerce
  • Address: No. 68 Jinzhou Avenue, Lugu High-tech Zone, Changsha City, Hunan Province
  • Website: https://www.yfdyf.cn/
  • Company Profile: The company was established by natural person Gao Yi and five corporate shareholders including Yifeng Investment as promoters, through the overall transformation of Yifeng Co., Ltd. into a joint stock company. The capital contributions of the six promoter shareholders at the time of the overall transformation into a joint stock company were verified by Tianjian's Capital Verification Report Tianjian Yan [2011] 2-22 issued on August 31, 2011, and the Business License with registration number 430700000011314 was obtained from the Changde Administration for Industry and Commerce on September 5, 2011.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Ningbo Meishan Bonded Port Area Houxin Venture Capital Partnership (Limited Partnership) Corporate 24102.09 19.88
2 Hong Kong Securities Clearing Company Ltd. Northbound Capital 19918.91 16.43
3 CAPITAL TODAY INVESTMENT XV (HK) LIMITED Corporate 11653.13 9.61
4 CAPITAL TODAY INVESTMENT XIV (HK) LIMITED Corporate 11587.08 9.56
5 Ningbo Meishan Bonded Port Area Yizhifeng Enterprise Management Partnership (Limited Partnership) Corporate 1078.89 0.89
6 CSI 500 Exchange Traded Open End Index Securities Investment Fund Fund 881.27 0.73
7 Jiao Yin Shi Luo De New Growth Hybrid Securities Investment Fund Fund 845.42 0.70
8 MORGAN STANLEY & CO. INTERNATIONAL PLC. QFII 797.46 0.66
9 Yin Hua Sheng Hong Bond Securities Investment Fund Class A Fund 369.88 0.31
10 Hua Fu Growth Trend Hybrid Securities Investment Fund Class A Fund 82.40 0.07

5. Concept Sectors

  • Convertible Bonds
  • Smart Healthcare
  • Family Doctor
  • Margin Trading & Securities Lending
  • High-Performance Stocks
  • QFII Heavy Positions
  • MSCI Constituent
  • QFII New Entries
  • Northbound Heavy Positions
  • Stock Connect Heavy
  • Free Cash Flow
  • SSE 380
  • Mid-Cap Growth
  • SZSE Growth

Remarks

  • Data update date: 2025-09-30
  • Data source: Public Market Information